Search results
FDA approves Cepheid’s Xpert HCV test and GeneXpert Xpress System
Medical Device Network· 2 days agoThe FDA's De Novo premarket review pathway, designated for...moderate-risk devices of a new type,...
Alnylam reveals positive Phase III results for rare heart disease drug vutrisiran
Clinical Trials Arena· 6 days agoRandomisation was stratified based on the patients’ use of Pfizer’s Vyndaqel/Vyndamax (tafamidis)—an...
Chronic kidney disease market to grow at 19.6 percent CAGR in seven major markets during 2023-33:...
Financial Express· 4 days agoGlobalData’s latest report “Chronic Kidney Disease: Seven-Market Drug Forecast and Market Analysis,”...
Karnataka CM Siddaramiah directs officials to ensure availability of treatment, medicines amid surge...
The Economic Times· 5 days agoBengaluru: Amid the recent surge in Dengue cases in Karnataka, State Chief Minister Siddaramiah has...
Eisai and Biogen launch Alzheimer's drug Leqembi in China - ET HealthWorld | Pharma
The Economic Times· 2 days agoLeqembi, which works by removing a toxic protein called beta amyloid from the brain, is the first...
Flu and Typhoid Cases Rise Due to Humidity and Rain, Say Doctors | Gurgaon News - Times of India
The Times of India· 17 hours agoGurgaon: Hospitals in the city have been witnessing a rise in the number of patients suffering from water-borne diseases over the past few days. Doctors said this was mainly ...
Punjab frames rules for timely detection of ILIs | Chandigarh News - Times of India
The Times of India· 2 days agoChandigarh: For timely detection and treatment, the Punjab health department has instructed all...
Special Bond with the doctor creates an atmosphere of trust for the patients to visit for check-ups...
The Times of India· 14 hours agoIn the olden days, a doctor-patient relationship was a unique one. In most cases, the patients...
Gujarat government runs statewide campaign to eradicate Sickle cell disease - ET HealthWorld
The Economic Times· 6 days agoNew Delhi: The Gujarat government commenced a statewide campaign to eradicate Sickle cell disease....
Novo Nordisk shares results from trial of semaglutide for type 2 diabetes and CKD
Clinical Trials Arena· 5 days agoA 24% risk reduction in kidney disease progression and mortality was observed in the semaglutide arm...